A fair number of diagnostic and pharmaceutical companies remain perplexed by the recent decision in the ‘Mayo vs Prometheus’ US Supreme Court case. Sara Reekmans at LC Patents explains why, depending on the interpretation of the decision, thousands of existing patents could be challenged.
Current Edition
Is there a Future for Medical/Diagnostic Patents in the US?
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
IPI Media © 2025, All Rights Reserved – Powered by Teksyte